1. National policy and strategies about prevention
and control of addiction. 2005. Tehran, Iran :
Headquarter against opiate abuse and smuggled.
2. Rahimimovaghar A : Guideline for prevention
and treatment of addiction. Tehran prevention of
vice cultural welfare organization, 1997
3. Ziaaddini H, ziaaddini MR. The household
survey of drug abuse in kerman, Iran. J Applied
sci : 2005 ; 5(2) : 380-2.
4. Nakhaee N, Divsalar K, Meimandi M, Dabiri S.
Estimating the prevalence of opiates use by
unlinked anonymous urine drug testing: a pilot
study in Iran. Substance use & misuse. 2008;
43:513 – 520.
5. Nasrollahzadeh D, Kamangar F, Aghcheli K,
Sotoudeh M, Islami F, Abnet CC, et al. Opium,
tobacco, and alcohol use in relation to
oesophageal squamous cell carcinoma in a highrisk area of Iran. Brit J Cancer. 2008; 98:1857 –
1863.
6. Masjedi MR, Naghan PA, Taslimi S,
Yousefifard M, Ebrahimi SM, Khosravi A, et al.
Opium could be considered an independent risk
factor for lung cancer: a case-control study.
Respiration. 2013;85(2):112-8.
7. Sadjadi A, Derakhshan MH, Yazdanbod A,
Boreiri M, Parsaeian M, Babaei M, et al.
Neglected role of hookah and opium in gastric
carcinogenesis: A cohort study on risk factors
and attributable fractions. International Journal
of Cancer. 2014;134(1):181-8.
8. Naghibzadeh-Tahami A KN, YazdiFeyzabadiV,Varzandeh M, Haghdoost AA.
Opium as a risk factor for upper gastrointestinal
cancers: a population-based case-control study
in Iran. Archives of Iranian medicine.
2014;17(1):2.
9. Akbari M, Naghibzadeh-Tahami A, Khanjani N,
Baneshi MR, Kamali E, Hesampour M, et
al.Opium as a Risk Factor for Bladder Cancer:
A Population-based Case-control Study in Iran.
Archives of Iranian medicine. 2015;18(9):567.
10. Naghibzadeh-Tahami A, Feyzabadi VY,
Khanjani N, Ashrafi-Asgarabad A ,Alizaeh H,
Borhaninejad VR, Moradi-Joo M, Zeinali M,
Zahedi MJ ,Aghaee-Afshar M, Haghdoost AA.
Can opium use contribute to a higher risk of
colorectal cancers? A matched case-control
study in Iran. Iranian journal of public health.
2016 Oct;45(10):1322 .
11. Lankarani KB, Khosravizadegan Z,
Naghibzadeh-Tahami A, Akbari M ,Khodadost
M, Honarvar B, Khodadost B, Goodarzi F,
Jokari K, Sekhavati E ,Tabrizi R. Opium use
and risk of lower gastrointestinal cancers :
Population-based case-control study in South of
Iran. International Journal of Cancer
Management. 2017;10(6).
12. Hadji M, Marzban M, Gholipour M, Rashidian
H, Naghibzadeh-Tahami A ,Haghdoost AA,
Rezaianzadeh A, Rahimi-Movaghar A, Moradi
A, Seyyedsalehi M, Poustchi H. National Study
of Opium and Cancer in Iran (IROPICAN :(
Study Protocol and Results of the Pilot Phase .
13. Asgari S, Nisal sarrafzadegan, Gholam-Ali
naderi. Effect of opium addiction on new and
traditional cardiovascular risk factors. Lipids in
health and disease. 2008 ; 7 : 42.
14. Bjornaas MA, Bekken AS, Ojlert A, Haldorsen
T. A 20-year prospective study of mortality and
cause of death among hospitalized opiod addicts
in oslo. BMC psychiatry 2008 ; 8. 8
15. Marmor M, Penh A, Widmer K, Ievin RI.
coronary artery disease and opioid use. Am j
cardiol 2004 ; 93(10) : 1295-1297
16. Sadeghian S, Darvish S, Davoodi G, Salarifar
M, Mahmoodian M, Fallah N, et al. The
association of opium with coronary artery
disease. European Journal of Cardiovascular
Prevention & Rehabilitation. 2007;14(5):715-7.
17. Sadr Bafghi SM, Rahei M, Bahadorzadeh L,
Namayeh SM. Is opium addiction a risk factor
for acute myocardial infarction?. Acta medica
Iranica 2005 ; 43(3) : 218-22.
18. Mann DL, Zipes DP, Libby P, Bonow RO.
Braunwald's heart disease e-book: a textbook of
cardiovascular medicine 10th ed. Elsevier
Health Sciences; 2014.
19. Davoodi G, Sadeghian S, Akhondzadeh S,
darvish S. A comparison of specifications, shortterm prognosis of acute myocardial infarction in
opium dependent patients and non dependents.
German j psychiatry 2005 ; 8 : 33-37.
20. American psychiatric association. Diagnostic
and statistical manual of mental disorders DSM-IV-TR 4th ed. Washington DC : american
psychiatric publishing ; 2000
21. Mann DL, Zipes DP, Libby P, Bonow RO.
Braunwald's heart disease: a textbook of
cardiovascular medicine: Elsevier Health
Sciences; 2014.
22. Masoumi M, Shahesmaeili A, Mirzazadeh A,
Tavakoli M. opium addiction and severity of
coronary artery disease : a case-control study.
Journal research of medical sciences 2010 ;
15(1) : 27-32
23. Aghaee-Afshar M, Khazaeli P, Behnam B,
Zadehkermani M, Ashraf-Ganjooei N. Presence
of Lead in Opium. Arch Iranian Med.2008;
11(5):553 – 554.
24. Salehi H, Sayadi A, Tashakori M, Yazdandoost
R, Soltanpoor N, Sadeghi H, et al. Comparison
of serum lead level in oral opium addicts with
healthy control group. Arch Iranian Med.2009;
12(6):555 – 558.
25. Amiri M, Amini R. A comparison of blood-lead
level (BLL) in opi-um-dependant addicts with
healthy control group using the graphite
furnace/atomic absorption spectroscopy (GFAAS) followed by chemometric analysis.Iran
Red Crescent Med J. 2012; 14(8):488 – 491.
26. Navas-Acien A, Guallar E, Silbergeld EK,
Rothenberg SJ. Lead exposure and
cardiovascular disease: a systematic review.
Environmental health perspectives. 2007:472-
82.
27. Vaziri N, Gonick H. Cardiovascular effects of
lead exposure. Indian Journal of Medical
Research. 2008;128(4):426.
28. Pyrgakis VN. Smoking and cardiovascular
disease. Hellenic J Cardiol. 2009;50(3):231-4.
29. Chen Z, Boreham J, editors. Smoking and
cardiovascular disease. Seminars in vascular
medicine; 2002.